» Articles » PMID: 9662379

Tissue Microarrays for High-throughput Molecular Profiling of Tumor Specimens

Overview
Journal Nat Med
Date 1998 Jul 14
PMID 9662379
Citations 1238
Authors
Affiliations
Soon will be listed here.
Abstract

Many genes and signalling pathways controlling cell proliferation, death and differentiation, as well as genomic integrity, are involved in cancer development. New techniques, such as serial analysis of gene expression and cDNA microarrays, have enabled measurement of the expression of thousands of genes in a single experiment, revealing many new, potentially important cancer genes. These genome screening tools can comprehensively survey one tumor at a time; however, analysis of hundreds of specimens from patients in different stages of disease is needed to establish the diagnostic, prognostic and therapeutic importance of each of the emerging cancer gene candidates. Here we have developed an array-based high-throughput technique that facilitates gene expression and copy number surveys of very large numbers of tumors. As many as 1000 cylindrical tissue biopsies from individual tumors can be distributed in a single tumor tissue microarray. Sections of the microarray provide targets for parallel in situ detection of DNA, RNA and protein targets in each specimen on the array, and consecutive sections allow the rapid analysis of hundreds of molecular markers in the same set of specimens. Our detection of six gene amplifications as well as p53 and estrogen receptor expression in breast cancer demonstrates the power of this technique for defining new subgroups of tumors.

Citing Articles

GATA3 amplification is associated with high grade disease in non-invasive urothelial bladder cancer but unrelated to patient prognosis.

Plage H, Frericks A, Hofbauer S, Furlano K, Weinberger S, Rossner F BMC Urol. 2025; 25(1):37.

PMID: 39979991 PMC: 11841250. DOI: 10.1186/s12894-025-01704-y.


How to Write a Pathology Research Paper-Basic Principles and Beyond-A Primer for Residents.

Kristiansen G APMIS. 2025; 133(2):e70007.

PMID: 39967554 PMC: 11836636. DOI: 10.1111/apm.70007.


Prognostic value of immune biomarkers in melanoma loco-regional metastases.

Hugdahl E, Aziz S, Klingen T, Akslen L PLoS One. 2025; 20(1):e0315284.

PMID: 39883679 PMC: 11781691. DOI: 10.1371/journal.pone.0315284.


Unlocking breast cancer in Brazilian public health system: Using tissue microarray for accurate immunohistochemical evaluation with limitations in subtyping.

Ruppenthal R, Pilar E, Santos J, Coelho R, Henriques C, Uchoa D Womens Health (Lond). 2025; 21:17455057241304654.

PMID: 39745077 PMC: 11694303. DOI: 10.1177/17455057241304654.


Carcinoembryonic Antigen Expression in Human Tumors: A Tissue Microarray Study on 13,725 Tumors.

Jansen K, Kornfeld L, Lennartz M, Rico S, Kind S, Reiswich V Cancers (Basel). 2024; 16(23).

PMID: 39682238 PMC: 11640007. DOI: 10.3390/cancers16234052.